Literature DB >> 1412102

The pulmonary physician and critical care. 2. The injured lung: conventional and novel respiratory therapy.

A Swami1, B F Keogh.   

Abstract

Several alternatives to conventional ventilation in acute lung injury are now available and have been investigated to a varying degree. The assessment of all such techniques is limited by difficulties in designing proper comparative studies and by the time needed to recruit a large number of appropriate patients with acute lung injury. A common theme of lung volume maintenance combined with strategies designed to limit the extent of ventilator induced lung damage has emerged and should encourage reassessment of the conventional approach. The results of several large prospective comparative studies are eagerly awaited. Meanwhile we may reasonably suggest that improvements in respiratory support, together with advances in microbiological and pharmacological treatment, have the potential for improving the persistently disappointing survival rate in acute lung injury.

Entities:  

Mesh:

Year:  1992        PMID: 1412102      PMCID: PMC463870          DOI: 10.1136/thx.47.7.555

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  54 in total

1.  Percutaneous extracorporeal CO2 removal in a patient with bullous emphysema with recurrent bilateral pneumothoraces and respiratory failure.

Authors:  A Pesenti; G P Rossi; P Pelosi; L Brazzi; L Gattinoni
Journal:  Anesthesiology       Date:  1990-03       Impact factor: 7.892

Review 2.  The management of adult respiratory distress syndrome: 2.

Authors:  B F Keogh; D N Hunter; C J Morgan; T W Evans
Journal:  Br J Hosp Med       Date:  1990-01

3.  Heart-lung transplantation for adult respiratory distress syndrome.

Authors:  V Tsang; T W Evans; C Morgan; M Yacoub
Journal:  Crit Care Med       Date:  1991-02       Impact factor: 7.598

4.  Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS.

Authors:  P Radermacher; B Santak; H J Wüst; J Tarnow; K J Falke
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

5.  Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome.

Authors:  K G Hickling; S J Henderson; R Jackson
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

6.  Comparison of conventional mechanical ventilation and high-frequency ventilation. A prospective, randomized trial in patients with respiratory failure.

Authors:  J M Hurst; R D Branson; K Davis; R R Barrette; K S Adams
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

Review 7.  Oxygen transport in adult respiratory distress syndrome and other acute circulatory problems: relationship of oxygen delivery and oxygen consumption.

Authors:  J G Weg
Journal:  Crit Care Med       Date:  1991-05       Impact factor: 7.598

8.  Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group.

Authors:  R C Bone; G Slotman; R Maunder; H Silverman; T M Hyers; M D Kerstein; J J Ursprung
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

9.  Pressure control inverse ratio ventilation as a method to reduce peak inspiratory pressure and provide adequate ventilation and oxygenation.

Authors:  D C Lain; R DiBenedetto; S L Morris; A Van Nguyen; R Saulters; D Causey
Journal:  Chest       Date:  1989-05       Impact factor: 9.410

10.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

Authors:  M Hallman; R Spragg; J H Harrell; K M Moser; L Gluck
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

View more
  3 in total

Review 1.  Treatment of newborn infants with inhaled nitric oxide.

Authors:  R H Mupanemunda; A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

Review 2.  Prevention and therapy of the adult respiratory distress syndrome.

Authors:  B Temmesfeld-Wollbrück; D Walmrath; F Grimminger; W Seeger
Journal:  Lung       Date:  1995       Impact factor: 2.584

3.  Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).

Authors:  D Häfner; R Beume; U Kilian; G Krasznai; B Lachmann
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.